Assessment of the efficacy of tilmicosin phosphate to eliminate Actinobacillus pleuropneumoniae from carrier pigs

Canadian Journal of Veterinary Research

Volumn 69, Issue 2, 2005, Pages 146-150

  Fittipaldi, N ^a   Klopfenstein, C ^b   Gottschalk, Marcelo ^a   Broes, A ^b,d   Paradis, M A ^c   Dick, C P ^c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Ctr de Developpement du Porc du Q   (Canada)

^c ELI LILLY AND COMPANY   (United States)

^d Génétiporc ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TILMICOSIN;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL TISSUE; ARTICLE; AUTOPSY; BACTERIAL PNEUMONIA; BACTERIUM CARRIER; BACTERIUM DETECTION; CONTROLLED STUDY; DRUG EFFICACY; ERADICATION THERAPY; FEEDING; NONHUMAN; POLYMERASE CHAIN REACTION; SWINE; TONSIL;

ACTINOBACILLUS INFECTIONS; ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMALS; ANTI-BACTERIAL AGENTS; CARRIER STATE; MACROLIDES; RANDOM ALLOCATION; SWINE; SWINE DISEASES; TONSIL; TREATMENT OUTCOME; TYLOSIN;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMALIA; BACTERIA (MICROORGANISMS); SUS SCROFA;

EID: 19644375405     PISSN: 08309000     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Taylor DJ. Actinobacillus pleuropneumoniae. In: Straw BE, D'Allaire S, Mengeling WL, Taylor DJ, eds. Diseases of Swine. Ames, Iowa: Iowa State University Press, 1999:343-354.
2. Blackall PJ, Klaasen HL, van den Bosch H, Kuhnert P, Frey J. Proposal of a new serovar of Actinobacillus pleuropneumoniae: serovar 15. Vet Microbiol 2002;84:47-52.
3. Mittal KR, Higgins R, Lariviere S, Nadeau M. Serological characterization of Actinobacillus pleuropneumoniae strains isolated from pigs in Quebec. Vet Microbiol 1992;32:135-148.
4. Sidibe M, Messier S, Lariviere S, Gottschalk M, Mittal KR. Detection of Actinobacillus pleuropneumoniae in the porcine upper respiratory tract as a complement to serological tests. Can J Vet Res 1993;57:204-208.
5. Inzana TJ, Mathison B. Serotype specificity and immunogenicity of the capsular polymer of Haemophilus pleuropneumoniae serotype 5. Infect Immun 1987;55:1580-1587.
6. Gottschalk M, Altman E, Charland N, De Lasalle F, Dubreuil JD. Evaluation of a saline boiled extract, capsular polysaccharides and long-chain lipopolysaccharides of Actinobacillus pleuropneumoniae serotype 1 as antigens for the serodiagnosis of swine pleuropneumonia. Vet Microbiol 1994;42:91-104.
7. Fenwick BW, Osburn BI. Immune responses to the lipopolysaccharides and capsular polysaccharides of Haemophilus pleuropneumoniae in convalescent and immunized pigs. Infect Immun 1986;54:575-582.
8. Gagne A, Lacouture S, Broes A, D'Allaire S, Gottschalk M. Development of an immunomagnetic method for selective isolation of Actinobacillus pleuropneumoniae serotype 1 from tonsils. J Clin Microbiol 1998;36:251-254.
9. Fittipaldi N, Broes A, Harel J, Kobisch M, Gottschalk M. Evaluation and field validation of PCR tests for detection of Actinobacillus pleuropneumoniae in subclinically infected pigs. J Clin Microbiol 2003;41:5085-5093.
10. Dritz SS, Chengappa MM, Nelssen JL, et al. Growth and microbial flora of nonmedicated, segregated, early weaned pigs from a commercial swine operation. J Am Vet Med Assoc 1996;208: 711-715.
11. Dufresne L. Financial evaluation of disease eradication. Adv Pork Prod 2002;13:143-162.
12. Salmon SA, Watts JL, Case CA, Hoffman LJ, Wegener HC, Yancey RJ Jr. Comparison of MICs of ceftiofur and other antimicrobial agents against bacterial pathogens of swine from the United States, Canada, and Denmark. J Clin Microbiol 1995;33: 2435-2444.
13. Moore GM, Basson RP, Tonkinson LV. Clinical field trials with tilmicosin phosphate in feed for the control of naturally acquired pneumonia caused by Actinobacillus pleuropneumoniae and Pasteurella multocida in swine. Am J Vet Res 1996;57:224-228.
14. Moore GM, Mowrey DH, Tonkinson LV, Lechtenberg KF, Schneider JH. Efficacy dose determination study of tilmicosin phosphate in feed for control of pneumonia caused by Actinobacillus pleuropneumoniae in swine. Am J Vet Res 1996;57:220-223.
15. Paradis MA, Vessie GH, Merrill JK, et al. Efficacy of tilmicosin in the control of experimentally induced Actinobacillus pleuropneumoniae infection in swine. Can J Vet Res 2004;68: 7-11.
16. Lechtenberg KF, Shryock TR, Moore G. Characterization of an Actinobacillus pleuropneumoniae seeder pig challenge-exposure model. Am J Vet Res 1994;55:1703-1709.
17. Paradis MA, Vessie GH, Merrill JK, et al. Evaluation of the efficacy of tilmicosin phosphate in feed (Pulmotil) for the prevention of Actinobacillus pleuropneumoniae challenge infection in swine. Proc 15th Int Pig Vet Soc 1998:196.
18. Andreasen M, Mousing J, Thomsen LK. No overall relationship between average daily weight gain and the serological response to Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae in eight chronically infected Danish swine herds. Prev Vet Med 2001;49:19-28.
19. Rohrbach BW, Hall RF, Hitchcock JP. Effect of subclinical infection with Actinobacillus pleuropneumoniae in commingled feeder swine. J Am Vet Med Assoc 1993;202:1095-1098.
20. Assavacheep P, Persson M, Luengyosluechakul S, et al. Actinobacillus pleuropneumoniae in Thai pig herds. Prevalence of serum antibodies and relation to performance. J Vet Med B Infect Dis Vet Public Health 2003;50:390-395.
21. Straw BE, Shin S, Callihan D, Petersen M. Antibody production and tissue irritation in swine vaccinated with Actinobacillus bacterins containing various adjuvants. J Am Vet Med Assoc 1990;196:600-604.
22. Paradis MA, Higgins R, Lariviere S, De Lasalle F, Wilson J, Dick, P. In-vitro antimicrobial activity of tilmicosin against field swine pathogens. Proc 17th Int Pig Vet Soc 2002:41.